Literature DB >> 17043493

Is rituximab a potential new therapy in systemic sclerosis? new evidence indicates the presence of CD20-positive B-lymphocytes in scleroderma skin.

Frank A Wollheim.   

Abstract

Entities:  

Year:  2004        PMID： 17043493     DOI： 10.1097/01.rhu.0000129090.86550.1e

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  6 in total

Review 1.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

2.  B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis.

Authors:  Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2010-04-22       Impact factor: 5.156

Review 3.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

4.  B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Int J Rheumatol       Date:  2011-08-03

5.  Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Athanassios C Tsamandas; Christina Kalogeropoulou; Alexandra Kazantzi; Chaido Sirinian; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Rheumatology (Oxford)       Date:  2009-05-15       Impact factor: 7.580

6.  Rituximab treatment in patients with systemic sclerosis and interstitial lung disease.

Authors:  Abdel Gaffar A Mohammed; Ammar Alshihre; Ibrahim Abdulrazag Al-Homood
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.